Each disease area and drug program in our pipeline takes us one step closer to transforming preclinical R&D using computational chemistry to discover small molecule drugs more efficiently than traditional approaches to deliver better medicines, faster.
R & D Pipeline
total pipeline depth
protein AREAS400+ Unique Targets
Targets with Validated Hits80+ Targets with Validated Hits
Atomwise has internal drug discovery programs across many disease areas including oncology, immunology, cardiology, neurology, and rare diseases.
Contact us to learn about licensing opportunities.